Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs

European Journal of Pharmacology

Volumn 339, Issue 1, 1997, Pages 1-9

  Masunaga, Hiroaki ^a   Ogawa, Hiromi ^a   Uematsu, Yasuhiro ^a   Tomizuka, Toshie ^a   Yasuda, Hiroshi ^a   Takeshita, Yasuyoshi ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

AF 102B; Muscarinic receptor agonists; Salivary gland; Sjogren's syndrome

Indexed keywords

2 METHYLSPILO(1,3 OXATHIOLANE 5,3' QUINUCLIDINE) HYDROCHLORIDE HEMIHYDRATE; ACETYLCHOLINE DERIVATIVE; MUSCARINIC AGENT; PILOCARPINE; SNI 2011; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; DOG; DRUG BLOOD LEVEL; DRUG EFFICACY; HEART RATE; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVATION; XEROSTOMIA;

ANIMALS; DOGS; FEMALE; MALE; MUSCARINIC AGONISTS; PILOCARPINE; QUINUCLIDINES; RATS; RATS, WISTAR; SALIVATION; SECRETORY RATE; THIOPHENES; TIME FACTORS;

EID: 0031578554     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01338-1     Document Type: Article

References (18)

1. Brown D.A., Fatherazi S., Garthwaite J., White R.D. Muscarinic receptors in rat sympathetic ganglia. Br. J. Pharmacol. 70:1980;577-592.
2. Caulfield M.P., Stubley J.K. Pilocarpine selectively stimulates muscarinic receptors in rat sympathetic ganglia. Br. J. Pharmacol. 76:1982;216.
3. 3 muscarinic receptors in rat parotid gland couple to two second messenger systems. Am. J. Physiol. 261:1991;C1063-C1073.
4. Dawes C. The composition of human saliva secreted in response to a gustatory stimulus and to pilocarpine. J. Physiol. 183:1966;360-368.
5. Greenspan D., Daniels T.E. Effectiveness of pilocarpine in postradiation xerostomia. Cancer. 59:1987;1123-1125.
6. Fox P.C., Van Der Ven P.F., Baum B.J., Mandel I.D. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg. Oral Med. Oral Pathol. 61:1986;243-245.
7. Iwabuchi Y., Masuhara T. Subtypes of the muscarinic receptors that mediate salivary secretion in the rat sublingual gland. Asia Pacific J. Pharmacol. 7:1992;197-202.
8. Iwabuchi Y., Masuhara T. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: Identification of a potential therapeutic agent for treatment of Sjögren's syndrome. Gen. Pharmacol. 25:1994;123-129.
9. Laniyonu A., Sliwinski-Lis E., Fleming N. Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells. Eur. J. Pharmacol. 188:1990;171-174.
10. Mandel I.D. The functions of saliva. J. Dent. Res. 66:1987;623-627.
11. Mandel I.D., Katz R. Effect of pilocarpine and a beta-adrenergic blocking agent on human saliva. Pharmacol. Ther. Dent. 1:1971;71-82.
12. Mandel I.D., Katz R., Zengo A., Kutscher A.H., Greenberg R.A., Katz S., Scharf R., Pintoff A. The effect of pharmacologic agents on salivary secretion and composition in man. I. Pilocarpine, atropine, and anticholinesterases. J. Oral Ther. Pharmacol. 4:1968;192-199.
13. Peters N.L. Snipping the thread of life. Arch. Intern. Med. 149:1989;2414-2420.
14. Schuller D.E., Stevens P., Clausen K.P., Olsen J., Gahbauer R., Martin M. Treatment of radiation side effects with oral pilocarpine. J. Surg. Oncol. 42:1989;272-276.
15. Sreebny L.M., Valdini A. Xerostomia, a neglected symptom. Arch. Intern. Med. 147:1987;1333-1337.
16. Weaver M.L., Tanzer J.M., Kramer P.A. Pilocarpine disposition and salivary flow responses following intravenous administration to dogs. Pharmaceutical Res. 9:1992;1064-1069.
17. Wilffert B., Davidesko D., De Jonge A., Thoolen M.J.M.C., Timermans T.P.B.M.W.M., Van Zwieten P.A. Role of ganglionic M-1 and M-2 receptors in the neuronal control of the cardiovascular system of the normotensive rat as determined with pilocarpine. Eur. J. Pharmacol. 95:1983;109-116.
18. Yamaoka K., Tanigawara Y., Nakagawa T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacol. Dyn. 4:1981;879-885.